Get startedLog in
    Picture of Stoke Therapeutics logo

    STOK — Stoke Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Stoke Therapeutics Q1 Operating Income USD 111.24 Million

    Picture of Stoke Therapeutics logoStoke Therapeutics
    13/05/2025 12:52
    May 13 (Reuters) - Stoke Therapeutics Inc STOK.O:

STOKE THERAPEUTICS Q1 REVENUE USD 158.569 MILLION VERSUS. IBES ESTIMATE USD 7.61 MILLION

STOKE THERAPEUTICS Q1 OPERATING EXPENSES USD 47.329 MILLION

STOKE THERAPEUTICS Q1 NET INCOME USD 112.879 MILLION VERSUS. IBES ESTIMATE USD -25.3 MILLION

STOKE THERAPEUTICS Q1 OPERATING INCOME USD 111.24 MILLION VERSUS. IBES ESTIMATE USD -29.2 MILLION

Source text: ID:nBw7M09vLa

Further company coverage: STOK.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Stoke Therapeutics

    See all news